Digital Immune Optimized and Selected Pan-Influenza Vaccine Antigens ‘DIOS-PIVa’

Lead Participant: DIOSYNVAX LTD.

Abstract

no public description

Lead Participant

Project Cost

Grant Offer

DIOSYNVAX LTD. £250,000 £ 250,000

Publications

10 25 50